12.32
price down icon2.49%   -0.315
pre-market  Pre-mercato:  12.25   -0.075   -0.61%
loading

Briacell Therapeutics Corp Borsa (BCTX) Ultime notizie

pulisher
Dec 04, 2025

BriaCell Therapeutics : Investor Presentation (1Dec2025 Investor Presentation) - marketscreener.com

Dec 04, 2025
pulisher
Dec 04, 2025

BriaCell Therapeutics (BCTXZ) Stock Analysis Report | Financials & Insights - Benzinga

Dec 04, 2025
pulisher
Dec 04, 2025

Will BriaCell Therapeutics Corp. Equity Warrant stock outperform Dow Jones indexQuarterly Profit Report & Long-Term Investment Growth Plans - Newser

Dec 04, 2025
pulisher
Dec 02, 2025

BriaCell to present positive breast cancer therapy data at SABCS By Investing.com - Investing.com Australia

Dec 02, 2025
pulisher
Dec 02, 2025

BriaCell Therapeutics (BCTXW) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 02, 2025

BriaCell Unveils Promising Clinical Data at 2025 SABCS - TipRanks

Dec 02, 2025
pulisher
Dec 02, 2025

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025 - Investing News Network

Dec 02, 2025
pulisher
Dec 02, 2025

BriaCell (BCTX) Shares Positive Clinical Results Ahead of 2025 S - GuruFocus

Dec 02, 2025
pulisher
Dec 02, 2025

BriaCell (Nasdaq: BCTX) shares survival, biomarker data; Phase 3 interim readout 1H2026 - Stock Titan

Dec 02, 2025
pulisher
Dec 02, 2025

Can BriaCell Therapeutics Corp. stock hit analyst price targetsMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

(BCT) Strategic Investment Report (BCT:CA) - news.stocktradersdaily.com

Dec 01, 2025
pulisher
Dec 01, 2025

Bicara Therapeutics (BCTX) Releases Promising Early Data from Ca - GuruFocus

Dec 01, 2025
pulisher
Dec 01, 2025

BriaCell files subsidiary financials and analysis with Canadian regulators By Investing.com - Investing.com Nigeria

Dec 01, 2025
pulisher
Dec 01, 2025

BriaCell files subsidiary financials and analysis with Canadian regulators - Investing.com

Dec 01, 2025
pulisher
Dec 01, 2025

BriaCell Therapeutics Corp Subsidiary Files Financial Statements - TradingView

Dec 01, 2025
pulisher
Nov 28, 2025

(BCT) Comprehensive Trading Strategy Report (BCT:CA) - news.stocktradersdaily.com

Nov 28, 2025
pulisher
Nov 28, 2025

What analysts say about BriaCell Therapeutics Corp stockEquity Performance Review & Fast Growing Portfolio Trading - earlytimes.in

Nov 28, 2025
pulisher
Nov 28, 2025

BCTXZ Insider Trading - Quiver Quantitative

Nov 28, 2025
pulisher
Nov 27, 2025

BriaCell Therapeutics Corp. (BCTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 27, 2025
pulisher
Nov 26, 2025

BriaCell Therapeutics to Present Promising Clinical Data at SABCS 2025 - The Globe and Mail

Nov 26, 2025
pulisher
Nov 25, 2025

BriaCell to present positive cancer treatment data at breast cancer symposium By Investing.com - Investing.com Australia

Nov 25, 2025
pulisher
Nov 25, 2025

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025 - Investing News Network

Nov 25, 2025
pulisher
Nov 25, 2025

BriaCell to present positive cancer treatment data at breast cancer symposium - Investing.com

Nov 25, 2025
pulisher
Nov 25, 2025

BriaCell Therapeutics Brief: Says to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS 2025 - marketscreener.com

Nov 25, 2025
pulisher
Nov 25, 2025

BriaCell Therapeutics (NASDAQ: BCTX) Highlights Metastatic Breast Cancer Phase 2/3 Data - Stock Titan

Nov 25, 2025
pulisher
Nov 22, 2025

How to Take Advantage of moves in (BCT) (BCT:CA) - news.stocktradersdaily.com

Nov 22, 2025
pulisher
Nov 22, 2025

BriaCell Expands Phase 3 Study in Metastatic Breast Cancer - MSN

Nov 22, 2025
pulisher
Nov 22, 2025

What analysts say about BriaCell Therapeutics Corp Equity Warrant stockDividend Stability Analysis & Exceptional Capital Trading - earlytimes.in

Nov 22, 2025
pulisher
Nov 20, 2025

BriaCell to Present Key Clinical Data at SABCS 2025 - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

BriaCell and Receptor.AI Partner on AI- driven Small Molecule Cancer Therapeutics - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

BriaCell (BCTX) Partners with Receptor.AI for Innovative Cancer Drug Development - GuruFocus

Nov 20, 2025
pulisher
Nov 20, 2025

Briacell and Receptor.AI to collaborate on AI driven small molecule cancer therapeutics - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

BriaCell and Receptor.AI Collaborate on AI-Driven Cancer Therapeutics - TipRanks

Nov 20, 2025
pulisher
Nov 20, 2025

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics - The Manila Times

Nov 20, 2025
pulisher
Nov 20, 2025

How BriaCell Therapeutics Corp. stock valuations compare to rivalsProfit Target & AI Forecasted Stock Moves - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why analysts maintain buy rating on BriaCell Therapeutics Corp. (8BT0) stockSwing Trade & Trade Opportunity Analysis - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How buyback programs support BriaCell Therapeutics Corp. (8BT0) stock - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why BriaCell Therapeutics Corp. (8BT0) stock trades below fair valueGold Moves & AI Enhanced Trading Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Published on: 2025-11-20 01:08:24 - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Why BriaCell Therapeutics Corp. (8BT0) stock remains top ratedMarket Sentiment Report & Entry Point Confirmation Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 11:18:19 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Using portfolio simulators with BriaCell Therapeutics Corp. Equity Warrant includedTrend Reversal & Weekly High Conviction Ideas - newser.com

Nov 19, 2025
$39.16
price down icon 1.10%
$100.48
price down icon 1.00%
$32.03
price up icon 1.10%
$95.99
price down icon 0.77%
biotechnology ONC
$331.27
price down icon 1.95%
$205.04
price down icon 0.84%
Capitalizzazione:     |  Volume (24 ore):